Skip to content

On-X Ascending Aortic Prosthesis ONXAAP-21Recalls & reported problems

On-X Life Technologies, Inc. · Bileaflet mechanical heart valve attached to a vascular prosthesis implanted in the aortic position · Class 3 · Implant

All models of On-X Ascending Aortic Prosthesis (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00851788001518), received between Jun 15, 2022 and Jan 29, 2024 — classified as 6 injuries.

4 other recalls cover devices cleared under the same FDA submission (P000037); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem6

Patient problems

  • Stroke/CVA2
  • Cardiac Arrest1
  • Heart Block1
  • Hemorrhagic Stroke1
  • Ischemia Stroke1
  • Renal Failure1
  • Thromboembolism1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 29, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL NOTIFICATION,"PATIENT IS IN THE POST-MARKET CLINICAL FOLLOW-UP STUDY PROTOCOL OF THE ON-X ASCENDING AORTIC PROSTHESIS (AAP) RETROSPECTIVE STUDY AND WAS IMPLANTED ON (B)(6) 2011 WITH A PREFABRICATED AAP DEVICE SN #(B)(6). ON (B)(6) 2015 (1.357 DAYS POST IMPLANT) WAS ADMITTED TO THE HOSPITAL WITH DIAGNOSIS OF CVA. INR WAS 1.5 PER MEDICAL RECORDS AT TIME OF HOSPITALIZATION. AN ECHOCARDIOGRAM WAS PERFORMED ON (B)(6) 2015 AFTER THIS EVENT SHOWING AVR ON-X 21MM WELL SEATED AND FUNCTIONING, PEAK OF 26MM AND MEAN OF 18MMHG AND NO MENTION OF VEGETATION. SHE WAS DISCHARGED ON 6APRIL2015 ON LOVENOX AND INCREASED INR RANGE OF 2.0-3.5. NO FURTHER MEDICAL INFORMATION AVAILABLE DUE TO LIMITED MEDICAL RECORDS PROVIDED."

    Patient problems: Stroke/CVA

    MAUDE report 18594664 ↗
  • InjuryDec 7, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, STUDY PATIENT EXPERIENCED ACUTE RENAL FAILURE ON (B)(6) 2022, 1-DAY FOLLOWING IMPLANT WITH THE DEVICE (IMPLANTED ON (B)(6) 2022).

    Patient problems: Renal Failure

    MAUDE report 15933807 ↗
  • InjuryDec 7, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, STUDY PATIENT EXPERIENCED A HEMORRHAGIC STROKE ON (B)(6) 2022, 7-DAYS FOLLOWING IMPLANT WITH THE DEVICE (IMPLANTED ON (B)(6) 2022).

    Patient problems: Hemorrhagic Stroke

    MAUDE report 15933756 ↗
  • InjuryDec 7, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT RECEIVED, STUDY PATIENT EXPERIENCED AN ISCHEMIC STROKE ON (B)(6) 2022, 1-DAY FOLLOWING IMPLANT WITH THE DEVICE (IMPLANTED ON (B)(6) 2022).

    Patient problems: Ischemia Stroke; Stroke/CVA; Thromboembolism

    MAUDE report 15933004 ↗
  • InjuryNov 28, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON-X ASCEND STUDY PATIENT (B)(6) EXPERIENCED CARDIAC ARREST ON (B)(6) 2022 WHICH LED TO A SERIOUS DETERIORATION IN THE HEALTH OF THE PATIENT AND PROLONGED THEIR HOSPITALIZATION. RE-OPERATION WAS PERFORMED ON (B)(6) 2022. CABG (CORONARY ARTERY BYPASS GRAFT) COMPLETED WITH THE REANASTAMOSIS OF THE RIGHT CORONARY ARTERY BYPASS GRAFT DUE TO CONCERN ABOUT COMPROMISE TO THE BLOOD FLOW TO THE RIGHT CORONARY ARTERY. THE ON-X VALVE REMAINS IMPLANTED. OUTCOME OF THE RE-OPERATION IS SYMPTOMS RESOLVED WITHOUT SEQUELAE.

    Patient problems: Cardiac Arrest

    MAUDE report 15870265 ↗
  • InjuryJun 15, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IN PERFORMING A PAPER CASE REPORT FORM (CRF) REVIEW OF THE AORTIC PROSTHESIS (AAP)- SINGLE SITE RETROSPECTIVE STUDY, THE FOLLOWING ADVERSE EVENT WAS DISCOVERED FOR SUBJECT (B)(6): ON 09JUN2015 6 DAYS POST IMPLANT, SUBJECT EXPERIENCED COMPLETE HEART BLOCK AND HAD A PERMANENT PACEMAKER IMPLANTED. THE SUBJECT WAS DISCHARGED THE FOLLOWING DAY.

    Patient problems: Heart Block

    MAUDE report 14708306 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P000037. One submission often covers many models, so check the product and lot details in each record.

  • Z-2133-2026 · Feb 1, 2026 · Open, Classified
    On-X Mitral Heart Valve with Conform-X Sewing Ring, Model: ONXMC-25/33
  • Z-1073-2019 · Jan 17, 2019 · Terminated
    On-X Aortic Heart Valve with Anatomic Sewing Ring Product Usage: The On-X Prosthetic Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native
  • Z-2715-2017 · Jun 12, 2015 · Terminated
    On-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic and mitral positio
  • Z-3108-2017 · Feb 12, 2014 · Terminated
    On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in th

Other Heart-Valve, Mechanical devices

All Heart-Valve, Mechanical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page